Terumo (OTCMKTS:TRUMY) Sees Large Volume Increase – Here’s Why

Terumo Corp. (OTCMKTS:TRUMY) shares saw unusually-strong trading volume on Wednesday . Approximately 670,774 shares changed hands during mid-day trading, an increase of 74% from the previous session’s volume of 386,321 shares.The stock last traded at $13.65 and had previously closed at $13.59.

Terumo Price Performance

The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.46 and a current ratio of 2.51. The company’s 50 day moving average price is $14.15 and its 200-day moving average price is $15.92. The company has a market cap of $21.61 billion, a price-to-earnings ratio of 24.42 and a beta of 0.74.

Terumo (OTCMKTS:TRUMY) last issued its earnings results on Friday, February 13th. The company reported $0.14 earnings per share for the quarter, missing analysts’ consensus estimates of $0.15 by ($0.01). The business had revenue of $1.94 billion for the quarter, compared to the consensus estimate of $1.82 billion. Terumo had a return on equity of 9.39% and a net margin of 12.35%.

Terumo Company Profile

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.